The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Biden condemns antisemitism in Holocaust remembrance speech
China celebrates 30 years of internet access, boasting over 1 billion users
Matthews scores as Maple Leafs beat Bruins 3
Kepler has 3 RBIs in return from injured list; Twins beat White Sox 7
Pope Francis appoints new bishop in Tennessee after former bishop's resignation under pressure
Malaysia: 10 killed after two military helicopters collide during training
Vista Outdoor, Salesforce rise; Tesla, Cardinal Health fall, Monday, 4/22/2024
World Championship should move from 'SMELLY' Crucible, insists snooker star
Australia and Papua New Guinea leaders trek toward WWII South Pacific battleground
Badosa shows signs of her old form in a win over Andreeva at the Italian Open
Suárez runs shutout streak to 25 innings as Phillies blank Reds 7